Neogen Chemicals receives ₹60 Crore on-account payment for Dahej plant fire loss
Neogen Chemicals received an additional ₹60 Crore insurance payment for the Dahej plant fire, bringing the total on-account received to ₹140 Crore. The company recognized a loss of ₹348.16 Crore. Replacement plant commissioning is expected in Q1 FY27, with interim production shifted to other sites.
The fire incident caused significant property damage and business interruption, requiring substantial insurance claims and a temporary halt in production at one facility. While mitigation steps are underway, the financial and operational impact is considerable.
The company received an additional insurance payment, which is positive, but the overall loss recognized is significant, and production remains suspended, indicating a neutral financial impact at this stage.
Neogen Chemicals Limited has received an additional on-account payment of ₹60 Crore from its insurance company towards the loss of property, plant, and equipment due to the fire incident at its Multi-Purpose Plant (MPP3)- Facility, warehouse, and tank farms in Dahej SEZ on March 5, 2025. This payment is based on the surveyors' interim report. The total on-account claim received to date amounts to ₹140 Crore.
The company has recognized a loss of ₹348.16 Crore (₹362.90 Crore on a consolidated basis) on account of damage to property, plant, equipment, and inventory, along with incidental charges. An insurance claim receivable of ₹334.60 Crore (₹348.82 Crore consolidated) has been recognized, considering the policy's deductibility and coverage.
Production at the affected MPP3 facility remains temporarily suspended. However, the construction of the replacement plant is progressing rapidly, with commissioning expected in Q1 FY27. To mitigate the impact on earnings and business disruption, Neogen Chemicals has shifted production of select specialty products to other sites with customer approval and is proceeding with planned expansions at its Patancheru Plant.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.